Burgopak successfully achieves US F=1 Child Resistant Effectiveness for new addition to its packaging range
Burgopak Healthcare & Technology has successfully achieved the U.S. Consumer Product and Safety Commission’s F=1 for child resistance for a new pack size. This is in conformity with US regulatory standards for poison prevention packaging.
The new pack uses the same innovative locking mechanism as the original child resistant design, which keeps the sliding blister tray and patient information leaflet (PIL) connected at all times. To open the pack and access the medication the patient pushes on two release buttons on either side of the pack with one hand while simultaneously pulling the highlighted tab with the other. The tray slides open to reveal the blister on one side with the PIL on the other. To close the pack the patient simply pushes the tab back into its original position, in doing so locking the tray back in place. The unique design keeps the blister, PIL and outer carton permanently connected, supporting better patient compliance through keeping vital patient information alongside the medication.
The new pack dimensions are 100 x 72 x 15 mm and can accommodate aluminium or PVC blisters sized up to 70 x 57 x 9 mm, with the maximum tablet/capsule count dependant on exact product specifications. During testing the new format achieved a pass rate of 96% for child resistance and 99% for senior friendly effectiveness from a certified test, while through a separate certified test achieved 98% for child resistance and 98% for senior friendly. This success through two separate client tests of the packaging format clearly demonstrates the pack’s robustness in design and function, while also being clear testament to Burgopak’s commitment to innovation and design excellence.
To receive a sample or for more information please get in contact.